We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
DB:41O
​
​
logo

Outlook Therapeutics (41O)

DB • 41O • US69012T3059

0.3988Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 27, 2026, ORTEX estimated 1.6% of free float sold short, 574.8 days to cover, cost to borrow 3.44%. Sign up for live short interest data.

Market Cap

117m USD | # 8301 in DE

Volume

5k shares | 2.81k USD

Shares Outstanding

243.45m

Free Float Shares

72.53% | 176.57m

Nasdaq:OTLK|
XTRA:41O

News

41O key data

Outlook Therapeutics (DB: 41O) has a market capitalization of $117.1M. Last close €0.40 (as of 2026-11-12); 52-week range €0.15 to €2.26. ORTEX data as of 2026-10-27: short interest was 1.64% of free float, 574.8 days to cover and the average cost to borrow was 3.44%. Sign up for live short interest data.

  • 41O news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.